Myeloma and Related Diseases Registry (MRDR)

Thank you to all MRDR participants, sites, research staff, investigators, and other collaborators, for your support of the registry. We wish you a safe and happy holiday season 😊

More information

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

7961

Patients accrued

5621

Patients with multiple myeloma

59

Number of approved sites

733

M1000 Biobank participants

Latest news

MRDR Annual Breakfast Meeting - Recording Available
07 Nov 2024

The recording of the meeting is now available to those who may have missed out!

Read more
MRDR Events at Blood 2024
02 Oct 2024

See where and when MRDR presentations are happening in Blood 2024!

Read more
MRDR Annual Breakfast Meeting 2024
30 Sep 2024

Please join us for breakfast at the MRDR Annual Breakfast Meeting at Blood 2024, 28th October

Read more
New MRDR Publication
27 Aug 2024

An MRDR paper on the development and validation of a discrete-event simulation model of MM disease outcomes has now been published!

Read more

Participating organisations